Dr. Sarah K. Wise, MD

Dr. Wise practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Dr. Wise's NPI, 1053348060, was assigned on June 26, 2006. Dr. Wise graduated from University of Texas Medical School at San Antonio in 2001. Dr. Wise holds Georgia license 053208.

Dr. Wise's primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Dr. Wise's primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. Dr. Wise is also affiliated with Emory University Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. Wise to 1 more hospital, 1 clinical lab and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wise practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngic allergy is Dr. Wise's primary specialty in the NPI Registry, under taxonomy code 207YX0602X. Dmand AI has Dr. Wise's licenses on file in 2 states: Georgia and South Carolina.

CMS data shows 343 Medicare services from Dr. Wise across 6 procedure codes in 2024, for 140 Medicare patients. Medicare paid $37,580 for them. Every service was in an office.

CMS counts 140 Medicare patients who saw Dr. Wise in 2024. The largest group is 65 to 74, with 76 patients. 70% of them have high blood pressure, and 69% have high cholesterol. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wise's median patient age at 55, with 58% women.

In 2024, Dr. Wise wrote 113 Medicare Part D claims for 50 patients. 83% of them were for generic drugs. CMS names the drug for 60 of them, across 4 drugs with 11 or more claims each, at $56,115 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Wise for performance year 2024, reported through an alternative payment model (APM). Dr. Wise accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wise as offering telehealth.

Dmand AI links 128 papers to Dr. Wise, published from 2011 to 2025. 2019 was the busiest year, with 14. The most frequent topics are Sinusitis, Nasal Polyps and Rhinitis. Dr. Wise has published most often in Int Forum Allergy Rhinol. Dr. Wise's most frequent co-authors are John M. Delgaudio, MD, Zara Marzban Patel, MD and Lauren Tashima Roland, MD.

Dmand AI links Dr. Wise to 1 clinical trial. Conditions studied include Olfaction Disorders and Sensation Disorders. Open Payments lists research payments to Dr. Wise that name 1 trial.

CMS Open Payments shows 130 general payments to Dr. Wise from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 84% of the total. Sanofi and Genzyme US Companies paid the most, $19,992. It also lists 2 research payments totaling $5,522 from 2016 to 2025, naming 1 clinical trial.

Dr. Wise graduated from University of Texas Medical School at San Antonio in 2001.